# Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

> **NCT02461134** · PHASE2 · TERMINATED · sponsor: **Actelion** · enrollment: 1 (actual)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **DRUG:** Ponesimod

## Key facts

- **NCT ID:** NCT02461134
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-29
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-03-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461134, "Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT02461134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*